-
-
-
-
-
-
-
Teladoc Health Announces Chief Financial Officer Transition
-
-
-
-
-
-
-
Teladoc (TDOC) PT Lowered to $9 at Truist Securities
-
-
-
-
-
-
-
Teladoc Health Reports Full Year and Fourth Quarter 2024 Results
-
-
-
-
-
-
-
Teladoc Health Reports Second Quarter 2024 Results
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc Health
-
-
-
-
-
-
-
BofA Securities Reiterates Neutral Rating on Teladoc (TDOC)
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, and Teladoc and Encourages Investors to Contact the Firm
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

